NR
Newfound Research’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $77K | Buy |
936
+113
| +14% | +$9.3K | 0.19% | 66 |
|
|
2022
Q2 | $78K | Buy |
823
+184
| +29% | +$17.4K | 0.17% | 86 |
|
|
2022
Q1 | $75K | Buy |
+639
| New | +$75K | 0.1% | 123 |
|
|
2021
Q4 | – | Sell |
-564
| Closed | -$64K | – | 128 |
|
|
2021
Q3 | $64K | Sell |
564
-372
| -40% | -$42.2K | 0.1% | 107 |
|
|
2021
Q2 | $97K | Buy |
936
+10
| +1% | +$1.04K | 0.19% | 18 |
|
|
2021
Q1 | $77K | Sell |
926
-550
| -37% | -$45.7K | 0.18% | 56 |
|
|
2020
Q4 | $135K | Buy |
1,476
+1,046
| +243% | +$95.7K | 0.35% | 17 |
|
|
2020
Q3 | $34K | Buy |
+430
| New | +$34K | 0.1% | 59 |
|